Blackhawk Growth Corp. is a growing public investment fund located in Calgary, AB. Blackhawk drives its growth by investing in equity and debt instruments of companies and generating positive returns with minimal risk for shareholders. The company's strategy is focused on investing in multiple companies across a variety of sectors across North America.

Blender Bites is a Canadian company involved in the development and marketing of a line of premium frozen food products with a focus on functionality. Blender Bites was founded in 2016 and sells a pre-portioned “easy smoothie” product that is free of any unnecessary inner plastic packaging. Blender Bites products are organic, vegan, non-GMO, gluten free, dairy free and soy free. They contain no added sugars and are made in Canada. Blender Bites products are distributed nationally across Canada and are currently sold in over 800 stores, including Sobeys, Safeway, Save on Foods, Whole Foods Market, Buy-Low/Nesters, IGA and Fresh Street, with a launch planned into the United States marketplace. Blender Bites anticipates expanding its plant-based footprint in North America through organic growth of the existing brand and through new acquisitions.

Listed on the Canadian Securities Exchange under the trading symbol “BTC” and "BTC.PR.A" and in the United States on the OTC Markets under the trading symbol "BTCWF",  Bluesky Digital Assets Corp., is building a high value digital currency enterprise.

Bluesky mines digital currencies, such as Bitcoin and Ether, and is developing value-added technology services for the digital currency market, such as proprietary technology solutions.

Offering a complete ecosystem of value-creation, Bluesky is targeting reinvesting appropriate portions of its digital currency mining profits back into its operations. A percentage of the profit will be invested in the development of a proprietary Artificial Intelligence ("AI") based technology.

Overall, Bluesky takes an approach that enables the Corporation to scale, and respond to changing conditions, within the still-emerging Blockchain industry. The Corporation is poised to capture value in successive phases as this industry continues to scale.

For more information please visit www.blueskydigitalassets.com

Braxia Scientific Corp.  is a medical solutions company that aims to reduce the illness burden of brain-based mental disorders (e.g., major depressive disorder). Its operations are primarily focused on (i) owning and operating multidisciplinary clinics providing treatment for mental health disorders and (ii) research activities related to discovering and commercializing novel drugs and delivery methods. 

Braxia Scientific develops ketamine and psilocybin derivatives and other psychedelic products from the Company’s IP development platform. Braxia Scientific, through Braxia Health,  operates multidisciplinary community-based clinics offering rapid-onset treatments for depression located in Mississauga, Toronto, Ottawa, Kitchener and Montreal.